DarioHealth Reports Results for Third Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
DarioHealth (DRIO) Tops Q3 EPS by 3c
October 28, 2019 6:31 AM EDTDarioHealth (NASDAQ: DRIO) reported Q3 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.87 million versus the consensus estimate of $1.9 million.
Q3 2019 Revenues of $1.87 million, a 13% sequential increase over Q2 2019, and a 0.6% decrease compared to Q3 2018Q3 2019 Gross Profit of $873,000, representing 46.7% of revenues, a sequential increase of 168% over Q2... More